Representative Bacillus sp. AM1 from Gut Microbiota Harbor Versatile Molecular Pathways for Bisphenol A Biodegradation by López Moreno, Ana et al.
 International Journal of 
Molecular Sciences
Article
Representative Bacillus sp. AM1 from Gut Microbiota Harbor
Versatile Molecular Pathways for Bisphenol A Biodegradation
Ana López-Moreno 1,2,† , Alfonso Torres-Sánchez 1,2,†, Inmaculada Acuña 2,3 , Antonio Suárez 2,3




Torres-Sánchez, A.; Acuña, I.; Suárez,
A.; Aguilera, M. Representative
Bacillus sp. AM1 from Gut Microbiota
Harbor Versatile Molecular Pathways
for Bisphenol A Biodegradation. Int.
J. Mol. Sci. 2021, 22, 4952. https://
doi.org/10.3390/ijms22094952
Academic Editor: Rustam Aminov
Received: 7 February 2021
Accepted: 24 February 2021
Published: 7 May 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Microbiology, Faculty of Pharmacy, University of Granada, Campus of Cartuja,
18071 Granada, Spain; alopezm@ugr.es (A.L.-M.); alfons_ats@ugr.es (A.T.-S.)
2 Instituto de Nutrición y Tecnología de los Alimentos, INYTA-Granada, 18100 Granada, Spain;
iacuna@ugr.es (I.A.); asuarez@ugr.es (A.S.)
3 Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Granada,
Campus of Cartuja, 18071 Granada, Spain
4 IBS: Instituto de Investigación Biosanitaria ibs., 18012 Granada, Spain
* Correspondence: maguiler@ugr.es; Tel.: +34-958-245129; Fax: +34-958-246235
† Authors contributed equally to this work.
Abstract: Human gut microbiota harbors numerous microbial species with molecular enzymatic
potential that impact on the eubiosis/dysbiosis and health/disease balances. Microbiota species
isolation and description of their specific molecular features remain largely unexplored. In the
present study, we focused on the cultivation and selection of species able to tolerate or biodegrade
the endocrine disruptor bisphenol A (BPA), a xenobiotic extensively found in food plastic containers.
Chemical xenobiotic addition methods for the directed isolation, culturing, Whole Genome Sequenc-
ing (WGS), phylogenomic identification, and specific gene-encoding searches have been applied to
isolate microorganisms, assess their BPA metabolization potential, and describe encoded catabolic
pathways. BPA-tolerant strains were isolated from 30% of infant fecal microbial culture libraries
analyzed. Most isolated strains were phylogenetically related to the operational taxonomic group
Bacillus amyloliquefaciens spp. Importantly, WGS analysis of microbial representative strain, Bacillus
sp. AM1 identified the four complete molecular pathways involved on BPA degradation indicating
its versatility and high potential to degrade BPA. Pathways for Exopolysaccharide (EPS) and Polyhy-
droxyalkanates (PHA) biopolymer synthesis were also identified and phenotypically confirmed by
transmission electronic microscopy (TEM). These microbial biopolymers could generally contribute
to capture and/or deposit xenobiotics.
Keywords: human microbiota; Bacillus; bisphenols; molecular pathways; enzymes; EPS; PHA
1. Introduction
The microorganisms that colonize the human gut are functionally diverse and highly
variable [1]. Four phyla, Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria,
dominate the human gut. Daily exposure to industrial xenobiotics found in dermal prod-
ucts, food, and beverage containers trigger alterations in gut microbiota composition [2].
Dysbiosis, an imbalance in the composition and metabolic capacity of our microbiota,
has been related to the cumulative intake of a wide variety of xenobiotic substances that
induce obesogenic phenotypes [3], and act as endocrine disruptors through microbiota
interaction [4,5]. Bisphenol A (BPA) and its analogs (bisphenol-B, -S, -F and -E), used as
building blocks of polycarbonate plastics, as well as parabens (methyl-, ethyl-, propyl- and
phenyl-paraben), used as antimicrobial preservatives, have been associated with metabolic
and endocrine/hormonal diseases [6,7]. Phthalates, such as di-(2-ethylhexyl) phthalate, are
used as plasticizers and have been shown to exert obesogenic effects, affect the reproduction
system, and modify key glycemic parameters [8,9]. Perchlorates, organophosphates [10],
and other pesticides trigger symptoms of diabetes and obesity [11].
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Numerous gut microorganisms belonging to the Firmicutes phylum possess a diverse
and versatile array of enzymes. Species within the Bacillus genus are consistently identified
in the human gut and are a source of enzymes with potential technological applications
in the modern food sector [12]. The use of bacterial enzymes in the current food industry
has gained increasing recognition in recent years as a result of the demand for new and
better products [13]. In this sense, due to the increase in the human population and
the growing need for products to satisfy the nutritional requirements of an increasingly
demanding population, enzymes of bacterial origin are presented as among the most
versatile alternatives in the current industrial context [14]. Commensal microorganisms
isolated from human microbiota could fulfill the criteria of safety assessment and the status
of Qualified Presumption of Safety (QPS) [15,16]. In this sense, most species within the
Bacillus subtilis cluster are considered QPS [17] and are increasingly considered as feed
additives [18].
Taxonomic classification of Bacillus species and the specific WGS description of their
encoded biochemical pathways are needed to consider the food and feed safety of Bacillus
strains [19]. Ecological and phenotypical heterogeneity within the Bacillus genus have
rendered pure 16S rDNA-based taxonomy inefficient to discern between Bacillus species,
even leading to misclassifications in the past [20]. Next-Generation Sequencing platforms
and in silico tools have been developed to perform appropriate phylogenomic classifica-
tions and predict metabolic pathways involved in industrial and environmental processes,
expanding the molecular knowledge of the enzymatic arsenal for BPA degradation in
Bacillus species. Few microbial cultivation studies explored the potential BPA degrading
capacity of Bacillus species for environmental bioremediation [21]. Recent approaches to
assess the degradation pathways of BPA in Bacillus and other microorganisms have pro-
vided a new field of research to understand in the context of industrial and environmental
biotechnology [22,23].
BPA is a dietary xenobiotic banned at specific levels. Because gut microbiota is a
potential source for screening the capacities of tolerance and biodegradation capacities,
particular microorganisms might provide endogenous bioremediation and could become
detoxifying probiotics. Thus, the main objective of the present study was to describe, for
the first time, BPA-tolerant microorganisms from the human gut and the specific pathways
that allow them to behave as active metabolizers of this endocrine disruptor, possibly
modulating its physiological impact. Culturing isolation strategies and WGS descriptions
are used to find the specific BPA-degrading genes involved in the degradation pathways.
2. Results and Discussion
2.1. BPA-Tolerant Microorganisms Isolated from Human Microbiota: 16S RNA Partial Gene
Identification and Phylogenetic Analysis
Our hypothesis was to seek human microbes capable of tolerating and metaboliz-
ing the endocrine disruptor BPA [4], the most important bisphenol in a large family of
chemicals that are utilized to produce polycarbonates and epoxy resins and found in
foods, drinks, and baby bottles. A comprehensive approach involved the culturing and
isolation of gut microbial species in BPA-enriched complete or minimal media for further
morphology, phylogenetical, biochemical, as well as WGS analyses was undertaken. It
is an untested innovative strategy for a rational and functional search of potential next
generation probiotics for biotechnological use in BPA detoxification. This study sets the
basis for future linked omics and multidisciplinary studies aimed at the identification of
new BPA-degrading microbes in the human gut and their association with the short and
long-term daily intake of BPA.
Isolation and identification of BPA-tolerant strains from microbiota samples were
successful from the different concentrations used [0.5; 10; 20 and 50 ppm] and demonstrated
a clear predominance of Firmicutes phylum taxa. This is one of the most populated phyla
in microbiota with wide compositional, clinical, and functional variability [24,25]. Out of
these 20 isolates analyzed, 83.3% were related to the genus Bacillus, and 16.7% of the strains
were distributed within Staphylococcus, Enterococcus, and Streptococcus genera (Table S1).
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However, the analysis of these minority genera was beyond the objective of the present
work. The phylogenetic tree based on partial 16S RNA gene of Bacillus spp. isolated
strains showed a main cluster related to B. amyloliquefaciens, B. velezensis and B. siamensis
(Figure 1), being only C1, C2 and B5 isolates different to the rest of Bacillus spp. The repeated
presence of closely related B. amyloliquefaciens isolates in approximately 30% of the analyzed
fecal samples suggested differential metabolic detoxifying potential of these species in
individuals under high dietary exposure level to BPA [7] or food endocrine microbiota
disruptors (EMD) [4].
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 3 of 14 
 
 
Isolation and identification of BPA-tolerant strains from microbiota samples were 
successful from the different concentrations used [0.5; 10; 20 and 50 ppm] and demon-
strated a clear predominance of Firmicutes phylum taxa. This is one of the most popu-
lated phyla in microbiota with wide compositional, clinical, and functional variability 
[24,25]. Out of these 20 isolates analyzed, 83.3% were related to the genus Bacillus, and 
16.7% of the strains were distributed within Staphylococcus, Enterococcus, and Streptococcus 
genera (Table S1). However, the analysis of these minority genera was beyond the objec-
tive of the present work. The phylogenetic tree based on partial 16S RNA gene of Bacillus 
spp. isolated strains showed a main cluster related to B. amyloliquefaciens, B. velezensis and 
B. siamensis (Figure 1), being only C1, C2 and B5 isolates different to the rest of Bacillus 
spp. The repeated presence of closely related B. amyloliquefaciens isolates in approximately 
30% of the analyzed fecal samples suggested differential metabolic detoxifying potential 
of these species in individuals under high dietary exposure level to BPA [7] or food en-
docrine microbiota disruptors (EMD) [4]. 
 
Figure 1. A phylogenomic tree based on partial 16S RNA gene (Table S1) of isolated strains of Ba-
cillus sp. and closely related species. The tree was inferred by the maximum-likelihood method. 
The species and strain names are shown, and accession numbers are indicated in parentheses. 
Bootstrap values after 1000 resamplings are indicated at branch nodes. Bar: 0.0020 nucleotide sub-
stitution per site. 
Moreover, preliminary data on parallel metagenomics analyses were in concordance 
with this percentage of Bacillus sp. presence (data not shown). We hypothesize that the 
long-term daily intake of xenobiotic compounds such as BPA or parabens present in food 
containers may select specific taxa groups in the intestinal microbiota, thus increasing or 
reducing microbial populations according to their enzymatic capacity to tolerate and 
metabolize BPA. Increased isolation of species Bacillus amyloliquefaciens in individuals 
might reveal a clinical potential impact through high tolerance to BPA [26]. 
Interestingly, the potential BPA metabolization by Bacillus spp. has solely been in-
vestigated in relation to environmental and bioremediation resources [22,23]. The present 
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Figure 1. A phylogenomic tree based on partial 16S RNA gene (Table S1) of isolated strains of Bacillus
sp. and closely related species. The tree was inferred by the maximum-likelihood method. The species
and strain names are shown, and accession numbers are indicated in parentheses. Bootstrap values
after 1000 resamplings are indicated at branch nodes. Bar: 0.0020 nucleotide substitution per site.
Moreover, preliminary data on parallel metagenomics analyses were in concordance
with this percentage of Bacillus sp. presence (data not shown). We hypothesize that the
long-term daily intake of xenobiotic compounds such as BPA or parabens present in food
containers may select specific taxa groups in the intestinal microbiota, thus increasing
or reducing microbial populations according to their enzymatic capacity to tolerate and
metabolize BPA. Increased isolation of species Bacillus amyloliquefaciens in individuals might
reveal a clinical potential impact through high tolerance to BPA [26].
Interestingly, the potential BPA metabolization by Bacillus spp. has solely been in-
vestigated in relation to environmental and bioremediation resources [22,23]. The present
study constitutes the first report on BPA-tolerant human microbiota species that might
became a new extensive biotechnological source of probiotics for plants, food, and clinical
purposes. In this sense, several Bacillus strains are proposed for being anti-obesogenic
probiotics [27,28]. Still, the major limitation for using these new potential probiotics is the
lack of standardized criteria and protocols for target disorders. Next-generation probiotics
for obesity-related diseases promise to improve the rational of clinical trial design and
outcomes [29]. Additional microbial food safety and risk assessments would be needed for
strains proposed for food and feed, including strain characterization and genome sequenc-
ing, screening for undesirable attributes and metabolites, and experimental evidence of
safety by appropriately designed safety evaluation studies [18,30].
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2.2. Identification of the Representative BPA-Tolerant Microbiota Strain and Morphological Features
All isolated and typified strains were able to tolerate between 0.5 and 50 ppm of
BPA. Bacillus sp. AM1 (B1) was the BPA-tolerant selected strain representing the main
phylogenetic cluster (Figure 1) for being further analyzed (phenotypic features and WGS).
This selection was done based on the following enzymatic and phenotypic characteristics
preliminary analyzed: the B1 strain was able to tolerate higher concentration of BPA;
B1 showed special morphological and phenotypic features, such as biopolymers EPS
and PHA production that can protect from the xenobiotic exposure (Figure 2), specific
gene-encoding enzymes for both biopolymers were also found in the WGS of Bacillus
sp. AM1 (Tables S2 and S3), and the phylogenetic identification as shown in Figure 1, B1
may represent the major close-related group. This cluster represented by the B1 strain
and the grouping of B3, B4, C3, C4, and C5 strains was closely related to the operational
B. amyloliquefaciens group [20], and became the most frequently identified related species
from the microbiota samples analyzed.
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The hydrolytic enzyme capacities of Bacillus sp. AM1 (Table 1) revealed similar re-
sults to those described for Bacillus amyloliquefaciens, B. velezensis, and B. siamensis, in-
cluding inulinase activity. Bacillus genus is considered of interest for its enzyme produc-
tivity for many manufacturing processes [33–35]. The antibiotic sensitivity testing re-
vealed that Bacillus sp. AM1 was resistant to ampicillin, ceftazidime, penicillin, and 
amoxicillin/clavulanic acid (Table 2). These resistances were previously described as in-
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30ºC for 72h (LC-MS/MS system for quantification).
Bacillus sp. AM1 is an anaerobic facultative rod with subterminal swollen spores. Pale
yellow colonies forming oleaginous drops in MRS medium are typical (Figure 2a). Similarly,
lipid, wax ester, or PHA producers showed similar morphologies and characteristics [31,32].
Transmission electron microscopy (TEM) revealed the presence of clear cytoplasmatic lipid
accumulations similar to PHA granule accumulation. We also observed biopolymers type
capsular EPS (Figure 2b).
The hydrolytic enzyme capacities of Bacillus sp. AM1 (Table 1) revealed similar results
to those described for Bacillus amyloliquefaciens, B. velezensis, and B. siamensis, including in-
ulinase activity. Bacillus genus is considered of interest for its enzyme productivity for many
manufacturing processes [33–35]. The antibiotic sensitivity testing revealed that Bacillus sp.
AM1 was resistant to ampicillin, ceftazidime, penicillin, and amoxicillin/clavulanic acid
(Table 2). These resistances were previously described as intrinsic resistance showed
commonly by Bacillus spp., not posing any safety concern [18].
Bacillus sp. AM1 was able to grow in BPA-enriched M9 medium (0.5 ppm) showing
slower colony development compared to the control and M9 containing glucose as sole
carbon source (0.5 ppm). Conversely, Bacillus sp. AM1 was not able to grow on M9 medium
containing BPS (0.5 ppm), an analogue of BPA, indicating that BPS may be toxic or cannot
be used as sole carbon source by this strain (Figure S1). Bacillus sp. AM1 was capable
of degrading 84.68% of BPA after 72 h, using a starting BPA concentration of 25 ppb
(Figure 2c). A similar pattern of biodegradation was shown by Bacillus sp. GZB [22].
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Table 1. Results derived from the enzymatic analysis of Bacillus sp. AM1.
Enzyme Test Microorganisms







Starch + + + ++ ++ ++
Carboxymethylcelulose − − − − − −
Gelatine − − − − − −
Inuline + − − − + +
Tween 80 − + + − − −
DNase ++ + + − − −






Ampicillin 10 R -
Amikacin 30 S 14
Ceftazidime 30 R -
Ciprofloxacin 5 S 40
Chloramphenicol 30 S 42
Clindamycin 2 S 22
Erythromycin 15 S 25
Gentamicin 10 S 22
Imipenem 10 S 50
Penicillin 10 R -
Rifampicin 30 S 29
Vancomycin 30 S 22
Kanamycin 30 S 19
Streptomycin 10 R -
Tetracycline 30 S 17
Co-Trimoxazole 25 S 39
Amoxicillin/
Clavulanic acid 20/10 R -
2.3. Whole Genome Sequence of Bacillus sp. AM1 Analysis
WGS of Bacillus sp. AM1 (GenBank CP047644.1) showed a total length (bp) of 4,203,926
and a G+C content value of 45.98 % (Figure S2). The genome of strain Bacillus sp. AM1
shared 67.67–98.36% ANI values with the Bacillus subtilis cluster (Table S4). DNA–DNA
hybridization (isDDH) relatedness between strain Bacillus sp. AM1 and the known Bacillus
species ranged from 28.2 to 83%. Results from the ANI and isDDH analyses and the phy-
logenomic trees based on 16S RNA gene (Figure 3a), gyrB (Figure 3b) and rpoB (Figure 3c)
suggested that strain Bacillus sp. AM1 belongs to the safe operational group B. amyloliq-
uefaciens [20], with no pathogenic or virulence factors or toxin genes. Moreover, rMLST
analysis showed match to 55 genes and, within them, to 6 genes unique and specific of
Bacillus sp. AM1: rpmD, rplM, rplI, rplE, rplA, rpsG. We are aware that many species of
Bacillus are difficult to be taxonomically classified under the universal rules; thus addi-
tional phylogenomic and phenotypic data will be obtained for a more precise classification.
Moreover, EPS and PHA biosynthesis complete gene pathways (Tables S2 and S3) were
also identified, confirming the features observed by TEM analyses (Figure 2b).
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2.4. Description of Putative BPA Biodegradation Pathways by Microbiota BPA-Tolerant Isolate
BPA biodegradation occurs due to the contribution and coordination of many ex-
pressed protein-coding genes. Complete gene-encoded enzymes for the four reference
pathways of BPA degradation were found in the Bacillus sp. AM1 genome, a major differ-
ence with Bacillus sp. GZB strain, isolated from recalcitrant environment, whose description
seemed to lack 30% of these enzymes [22]. Description of reaction steps, specific enzymes,
EC number, genes loci, and protein ID from each pathway are shown in Figure 4. This ver-
satile gene arsenal for BPA metabolization enzymes should be confirmed with functional
and chemical analyses, but underscores the huge potential of BPA biodegradation, possibly
generating intermediate metabolites with more or less estrogenic-linked effects [22,36].
Our results suggest that the establishment of routes linked to the degradation of estro-
genic xenobiotics, such as BPA, involves the participation of a large number of microbial
enzymes whose joint activity entails the production of a multitude of intermediate less
toxic byproducts which can even be found related to other metabolic routes or destined to
the energy production through the Cycle of Tricarboxylic Acids [23]. Likewise, numerous
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Figure 4. Proposed Biodegradation Pathways of BPA based on the WGS analysis of Bacillus sp. AM1: Reaction steps, Enzymes, EC number, protein ID, and specific genes loci. Figure 4. Proposed Biodegradation Pathways of BPA based on the WGS a alysis of Bacillus sp. AM1: Reaction steps,
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Lobos et al. [39] and Sasaki et al. [40] showed the existence of microorganisms belong-
ing to Sphingomonas and Bacillus genera capable of using BPA as a carbon source through its
degradation in multiple stages, with the production of end byproducts of variable toxicity.
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3. Materials and Methods
3.1. Tolerant-BPA bacterial Isolation from Human Gut Microbiota with Biotechnological Interest
Ten microbial isolates from fecal human microbiota collections of 0 to 1 year old infants
(Isolates B- Project INFABIO) and 6–8-year-old children (Isolates C-Project OBEMIRISK)
were obtained by a serial dilution method, exposition to different BPA concentrations
[0.5, 10, 20, and 50 ppm] during 72 h and further spreading in BHI/MRS media incubated
under aerobic and anaerobic conditions (anaerobic jars anaerocult®) at 37 ◦C.
The BPA-tolerant bacterial colonies with distinguishing features were isolated as pure
culture for subsequent morphological, phenotypic and genotypic identifications: bacterial
cell counts, gram staining, spore staining, capsule staining, catalase activity, oxidase, and
motility tests.
3.2. Genomic DNA from Tolerant-BPA Bacterial Isolates, Taxonomy Identification and
Phylogenetic Analysis
Genomic DNA was extracted using DNAeasy columns (Qiagen®, Germany) follow-
ing the manufacturing instructions. The isolated DNA was quantified using Nanodrop
(Thermo Scientific) and biophotometer (Eppendorf® D30). The quality of DNA was moni-
tored through gel electrophoreses. 16S RNA gene sequencing of selected bacterial strains
was done by Sanger method (IPBLN Service). Forward and reverse sequences were pro-
vided separately. Reverse sequence was converted to complementary sequence with
Chromas Pro 2.0 software (Technelysium Pty Ltd., Tewantin, Australia). Sequences were
inspected for maximum homology against GenBank using NCBI’s BLASTn program. The
collection of 16S RNA partial gene sequences is done using the Ezbiocloud platform.
3.3. Morphological Features and Identification of BPA-Tolerant Bacterial Strains
The selection of a representative sample from fecal BPA-tolerant microorganisms for
further phenotypic and WGS analysis was done according to specific phenotypic features
and specific phylogenetic classification.
Transmission electron microscopy was used to examine possible structural changes in
the selected strain. The samples were obtained after exposing the bacteria to the different
BPA treatments. The techniques detailed below were carried out in the Laboratory for the
Preparation of Biological Samples of the Microscopy Service of the Center for Scientific
Instrumentation (CIC) of the University of Granada. Samples were fixed with 2.5% glu-
taraldehyde in sodium cacodylate buffer (pH7.4, 0.05M) for 24 h at 4 ◦C. After washing
them three times in sodium cacodylate buffer (pH7.4, 0.1M) for 15 min, the post-fixation
was carried out with 1% osmium tetroxide + 1% potassium ferricyanide in water for 2 h.
It was washed again three times in water 15 min. And dehydration was realized using
ascending ethanol gradients (50%, 70%, 90%, and 100%) for 15 min. Subsequently, the
infiltration was carried out in a mixture of ethanol/resin (Epon 812) 2:1, 2:2 and 1:2 for 1 h
and then it was the inclusion in pure resin overnight. After polymerization at 60 ◦C for
48 h, ultra-fine sections of 700 Angstrom were made (in a Leica Ultracut R ultramicrotome)
deposited on copper grids and contrasted with uranyl acetate and lead citrate.
The enzymatic assay were also determinate for starch, carboxymethyl cellulose, gelatin,
inulin, tween 80, DNase supplemented media were used to test several enzymes production
according to complementary methodologies previously described [41,42].
The antimicrobial resistance patterns of Bacillus sp. AM1 to 17 clinically important
antibiotics, included those antibiotics recommending on the EFSA guidelines for testing
antimicrobial susceptibility of the Bacillus species [43], were conducted using the agar
disc-diffusion method. The strains were characterized as sensitive or resistant based on
the size of the inhibition zones around each disc, according to the National Committee for
Clinical Laboratory Standards (CLSI) criteria [44].
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3.4. BPA Tolerance Testing
BPA biodegradation capacity was tested in TSB liquid cultures of Bacillus sp. AM1
exposed to 25 ppb concentration of BPA at 30 ◦C during 72 h. Microbial preparations were
measured through LC-MS/MS system for BPA quantification. Minimal medium 9 (M9)
and M9 containing BPA (0.5 ppm) as sole carbon source were used for the isolation of BPA
tolerant or biodegradation strain. M9 containing glucose (0.5 ppm) and M9 containing BPS
(0.5 ppm) were also used to compare the growth ability. Chemicals, reagents, instrumenta-
tion and software for bisphenols determination were carried out by CIC services under
validated procedures previously described by García-Córcoles et al. [45].
3.5. Whole Genome Sequence of BPA-Tolerant Bacterial Strain
Genomic DNA extraction for WGS: Bacillus sp. AM1 (B1) selected for its phenotypic
characteristics and its potential in biotechnology was inoculated in 2 mL nutrient broth,
followed by overnight incubation at 37 ◦C. The cells were harvested by centrifugation at
5000× g for 10 min. Genomic DNA was extracted using DNAeasy columns (Qiagen®,
Germany) as previously described.
High-throughput sequencing: Shotgun library preparation of Bacillus sp. AM1 (B1)
strain was performed using the Nextera DNA Sample Preparation kit (Illumina, USA).
Clusters generation and the sequencing were performed using the TruSeq™ PE Cluster
kit v2-cBot-HS and TruSeq SBS v3-HS (200 cycle) kit respectively (Ilumina, USA). The
sequencing was performed on the HiScan SQ sequencer (Illumina, USA).
Genome assembly and annotation: Hybrid de novo assembly was performed with
Illumina short reads (c.a. 440X coverage, 150bp pair end reads) and Oxford Nanopore long
reads (c.a. 1800X coverage) using Unicycler1 with the “conservative” option and threads
10 parameter [46].
3.6. Whole Genome Sequence Analyses
3.6.1. Phylogenomic Analysis
Genome-based taxonomic classification and genome assembly were searched at
Microbial Genomes Atlas (MiGA) online server (http://www.microbial-genomes.org
accessed on 20 February 2021) that uses NCBI non-redundant prokaryotic genomes
database, JSpeciesWS (http://jspecies.ribohost.com/jspeciesws accessed on 20 February
2021), and TrueBacTM ID system from the EzBioCloud server (https://www.ezbiocloud.
net/contents/genome accessed on 20 February 2021). The species identification carried
out in TrueBac-ID was based on the comparison of average nucleotide sequence identity
(ANI) between the genomes of Bacillus sp. AM1 and the related type strains. For
a reliable identification of the strains, the Type (Strain) Genome Server (TYGS) was
employed. Prediction from identified Ribosomal Multilocus Sequence Typing (rMLST)
alleles linked to genomes (53 rps genes) was used as a means of integrating microbial
taxonomy and typing [47]. 16S RNA gene and the housekeeping genes gyrB and rpoB
sequences were used for phylogenomic identification.
Prokaryotic genome comparisons were performed by ANI calculator using the Or-
thoANIu algorithm available on Ezbiocloud [48]. Digital or isDDH analyses were carried
out by Genome-to-Genome Distance Calculator (GGDC) (formula 2) [49].
3.6.2. Molecular and Gene Prediction and Annotations
Draft Bacillus sp. AM1 genome was annotated using the NCBI Prokaryotic Genome
Annotation Pipeline (PGAP). The functional annotation of genes was also carried out us-
ing web-based Rapid Annotation Using Subsystem Technology (RAST) annotation server
(http://rast.theseed.org/FIG/rast.cgi accessed on 20 February 2021). Protein coding genes
were scanned for their organization into operons using the web server Operon-mapper.
Functional annotation of genes in terms of Kyoto Encyclopedia of Genes and Genomes
(KEGG) orthology assignments and predictions of KEGG pathways were carried out through
KEGG Automatic Annotation Server (KAAS) server (https://www.genome.jp/kegg/kaas/
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accessed on 20 February 2021) using bi-directional best hit (BBH) method in GhostZ. Sim-
ilarly, the Bacillus sp. AM1 genome were also scanned for cluster of orthologous groups
(COGs) annotations using eggNOG-mapper v2 (http://eggnog-mapper.embl.de accessed
on 20 February 2021). Automated Carbohydrate-active enzyme ANnotation web server, (db-
CAN meta server (http://bcb.unl.edu/dbCAN2/blast.php accessed on 20 February 2021),
was employed to annotate Carbohydrate-Active enZYmes (CAZy).
3.6.3. Identification of Microbial Enzymes Isolated from Bisphenol A Tolerant Microorganisms
Specific genes and amino acid sequences of the BPA-tolerant representative microor-
ganism were searched by screening according to phenotypic and chemical characteristics
such as EPS, PHA, and other enzymes related to the BPA degradation pathways: quinol-
enzymes, laccase, through BLAST (NCBI), EZBIOCLOUD, BRENDA, UNIPROT, and
EXPASY. A more exhaustive and combined analysis using the KEGG database (Ky-
oto Encyclopedia of Genes and Genomes) allowed corroborating the identity of the
enzymes involved in metabolic pathways of BPA degradation previously describe by
Li et al. [22]. EC numbers results essential for the screening in WGS Bacillus sp. AM1
protein encoding genes.
4. Conclusions
This study is the first report on the isolation of BPA-degrading microbes from the
human gut and its complete description of BPA biodegradation pathways. The isolation
of strains belonging to the Firmicutes phyla from human microbiota able to biodegrade
BPA was successful through a BPA-enriched media and a directed cultivation approach.
WGS analyses of representative Bacillus sp. AM1 allowed taxonomic and phylogenomic
identifications, relevant phenotypic features confirmation, and safety assessment aspects.
Bacillus sp. AM1 WGS revealed the presence of a complete arsenal of genes that encode
enzymes for versatile BPA degradation; this might open avenues for the investigation of the
use of these strains for environment, feed and food industries, and/or to explore the clinical
modulation impact on endocrine pathogenesis modulation by BPA-degrader species.
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